Immunosuppression reduction for BK virus nephropathy

A case for caution

K. L. Womer, Giselle Guerra, K. Dibadj, Y. Huang, A. Kazory, B. Kaplan, T. R. Srinivas

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

BK virus nephropathy (BKVN) is increasingly recognized as a major cause of renal allograft failure. Recent reports demonstrate that prompt reduction of immunosuppression upon detection of persistent viremia can be associated with resolution of viremia, with minimal risk of acute rejection (AR). However, these experiences in general have occurred in centers with low baseline risks of AR. It is possible that a finer balance between overimmunosuppression and the risk of AR may exist in centers that routinely transplant patients with higher risk of AR. Thus the risk/benefit of this strategy may be altered in these centers. We report a case of antibody-mediated rejection that followed reduction of immunosuppression for BKVN diagnosed more than 3 months after the onset of viremia. This rejection episode resulted in a greater decrease in graft function than the initial BKVN episode. Issues relevant to the management of these patients are discussed, including the need for improved immune monitoring assays to determine more accurately the balance between infection and rejection.

Original languageEnglish
Pages (from-to)244-248
Number of pages5
JournalTransplant Infectious Disease
Volume9
Issue number3
DOIs
StatePublished - Sep 1 2007
Externally publishedYes

Fingerprint

BK Virus
Immunosuppression
Viremia
Transplants
Immunologic Monitoring
Renal Insufficiency
Allografts
Antibodies
Infection

Keywords

  • Acute rejection
  • BK virus nephropathy
  • Dendritic cells
  • Immune monitoring
  • Polyclonal antibody
  • Polyomavirus
  • Renal transplant

ASJC Scopus subject areas

  • Transplantation
  • Microbiology (medical)
  • Immunology

Cite this

Immunosuppression reduction for BK virus nephropathy : A case for caution. / Womer, K. L.; Guerra, Giselle; Dibadj, K.; Huang, Y.; Kazory, A.; Kaplan, B.; Srinivas, T. R.

In: Transplant Infectious Disease, Vol. 9, No. 3, 01.09.2007, p. 244-248.

Research output: Contribution to journalArticle

Womer, KL, Guerra, G, Dibadj, K, Huang, Y, Kazory, A, Kaplan, B & Srinivas, TR 2007, 'Immunosuppression reduction for BK virus nephropathy: A case for caution', Transplant Infectious Disease, vol. 9, no. 3, pp. 244-248. https://doi.org/10.1111/j.1399-3062.2007.00204.x
Womer, K. L. ; Guerra, Giselle ; Dibadj, K. ; Huang, Y. ; Kazory, A. ; Kaplan, B. ; Srinivas, T. R. / Immunosuppression reduction for BK virus nephropathy : A case for caution. In: Transplant Infectious Disease. 2007 ; Vol. 9, No. 3. pp. 244-248.
@article{e3c2e00f52fb478c82054155f51bdf83,
title = "Immunosuppression reduction for BK virus nephropathy: A case for caution",
abstract = "BK virus nephropathy (BKVN) is increasingly recognized as a major cause of renal allograft failure. Recent reports demonstrate that prompt reduction of immunosuppression upon detection of persistent viremia can be associated with resolution of viremia, with minimal risk of acute rejection (AR). However, these experiences in general have occurred in centers with low baseline risks of AR. It is possible that a finer balance between overimmunosuppression and the risk of AR may exist in centers that routinely transplant patients with higher risk of AR. Thus the risk/benefit of this strategy may be altered in these centers. We report a case of antibody-mediated rejection that followed reduction of immunosuppression for BKVN diagnosed more than 3 months after the onset of viremia. This rejection episode resulted in a greater decrease in graft function than the initial BKVN episode. Issues relevant to the management of these patients are discussed, including the need for improved immune monitoring assays to determine more accurately the balance between infection and rejection.",
keywords = "Acute rejection, BK virus nephropathy, Dendritic cells, Immune monitoring, Polyclonal antibody, Polyomavirus, Renal transplant",
author = "Womer, {K. L.} and Giselle Guerra and K. Dibadj and Y. Huang and A. Kazory and B. Kaplan and Srinivas, {T. R.}",
year = "2007",
month = "9",
day = "1",
doi = "10.1111/j.1399-3062.2007.00204.x",
language = "English",
volume = "9",
pages = "244--248",
journal = "Transplant Infectious Disease",
issn = "1398-2273",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Immunosuppression reduction for BK virus nephropathy

T2 - A case for caution

AU - Womer, K. L.

AU - Guerra, Giselle

AU - Dibadj, K.

AU - Huang, Y.

AU - Kazory, A.

AU - Kaplan, B.

AU - Srinivas, T. R.

PY - 2007/9/1

Y1 - 2007/9/1

N2 - BK virus nephropathy (BKVN) is increasingly recognized as a major cause of renal allograft failure. Recent reports demonstrate that prompt reduction of immunosuppression upon detection of persistent viremia can be associated with resolution of viremia, with minimal risk of acute rejection (AR). However, these experiences in general have occurred in centers with low baseline risks of AR. It is possible that a finer balance between overimmunosuppression and the risk of AR may exist in centers that routinely transplant patients with higher risk of AR. Thus the risk/benefit of this strategy may be altered in these centers. We report a case of antibody-mediated rejection that followed reduction of immunosuppression for BKVN diagnosed more than 3 months after the onset of viremia. This rejection episode resulted in a greater decrease in graft function than the initial BKVN episode. Issues relevant to the management of these patients are discussed, including the need for improved immune monitoring assays to determine more accurately the balance between infection and rejection.

AB - BK virus nephropathy (BKVN) is increasingly recognized as a major cause of renal allograft failure. Recent reports demonstrate that prompt reduction of immunosuppression upon detection of persistent viremia can be associated with resolution of viremia, with minimal risk of acute rejection (AR). However, these experiences in general have occurred in centers with low baseline risks of AR. It is possible that a finer balance between overimmunosuppression and the risk of AR may exist in centers that routinely transplant patients with higher risk of AR. Thus the risk/benefit of this strategy may be altered in these centers. We report a case of antibody-mediated rejection that followed reduction of immunosuppression for BKVN diagnosed more than 3 months after the onset of viremia. This rejection episode resulted in a greater decrease in graft function than the initial BKVN episode. Issues relevant to the management of these patients are discussed, including the need for improved immune monitoring assays to determine more accurately the balance between infection and rejection.

KW - Acute rejection

KW - BK virus nephropathy

KW - Dendritic cells

KW - Immune monitoring

KW - Polyclonal antibody

KW - Polyomavirus

KW - Renal transplant

UR - http://www.scopus.com/inward/record.url?scp=34547728125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547728125&partnerID=8YFLogxK

U2 - 10.1111/j.1399-3062.2007.00204.x

DO - 10.1111/j.1399-3062.2007.00204.x

M3 - Article

VL - 9

SP - 244

EP - 248

JO - Transplant Infectious Disease

JF - Transplant Infectious Disease

SN - 1398-2273

IS - 3

ER -